Live News REGULATION FLASH L impact Sep 30, 2026, 06:35 AM UTC Bayer Says Bluerock Therapeutics' Investigational Cell Therapy Lemiretprocel (Opct-001) Granted Orphan Drug FDA, EMA Designations BAYER AG XETR:BAYN BAYN SquawkNews Newsroom